Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2023-04-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. It details the approval of various reports and proposals including the 2022 Annual Report, 2022 Supervisory Board Work Report, 2022 Financial Final Report, profit distribution plan, and the 2023 Q1 report. The document repeatedly states that the detailed reports are disclosed separately on the official information disclosure website (cninfo.com.cn). The document itself is relatively short (2925 characters) and serves as a formal announcement of the Supervisory Board's meeting resolutions rather than containing the full reports or detailed financial data. According to the "Menu vs Meal" rule, this is an announcement of resolutions and references to reports rather than the reports themselves. Therefore, the document fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-04-17 Chinese
东兴证券关于深圳市美好创亿医疗科技股份有限公司2022年度持续督导跟踪报告
Regulatory Filings Classification · 95% confidence The document is titled as a "2022年度持续督导跟踪报告" which translates to "2022 Annual Continuous Supervision Tracking Report" by the sponsoring institution Dongxing Securities Co., Ltd. for the company Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. The content includes detailed supervision work overview, findings, company and shareholder commitments, and other matters related to ongoing monitoring and compliance. It is not a full annual report or financial statement but a regulatory continuous supervision report typically required by securities exchanges or regulatory bodies to monitor compliance and governance of listed companies. The document length is 2750 characters, which is relatively short and focused on supervision activities rather than financial results or management discussion. This type of document fits best under Regulatory Filings (RNS) as it is a compliance and monitoring report rather than a financial report or announcement of voting results, management changes, or capital updates.
2023-04-17 Chinese
2022年度独立董事述职报告（李勉先生）
Board/Management Information Classification · 95% confidence The document is titled as the "2022年度独立董事述职报告" which translates to "2022 Annual Independent Director's Work Report." It is a detailed report by an independent director about their duties, meeting attendance, opinions on board resolutions, supervision activities, and training during the 2022 fiscal year. The content focuses on governance, oversight, and the independent director's role rather than financial results or audit opinions. It is not an announcement or a brief notice but a substantive report on management and board activities. This fits best under Board/Management Information (MANG), which covers announcements related to board or senior management activities and reports. The document length is 2757 characters, which is relatively short but contains detailed narrative about board duties and independent director activities, not just a notice or announcement. Therefore, the classification is MANG with high confidence.
2023-04-17 Chinese
关于提请股东大会授权董事会办理以简易程序向特定对象发行股票的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. regarding a proposal to the shareholders' meeting to authorize the board of directors to handle a simplified procedure for issuing shares to specific investors. It details the terms of the proposed share issuance, including the amount, pricing, restrictions, and authorization period. The document is a formal announcement about a capital raising activity requiring shareholder approval, not the actual issuance report or financial statements. It is not a full financial report, earnings release, or regulatory certification. The content fits the category of Capital/Financing Update (CAP) as it provides detailed information about a financing activity and the authorization process for issuing new shares.
2023-04-17 Chinese
2022年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2022 年年度报告摘要" which translates to "2022 Annual Report Summary." It contains detailed financial data for the year 2022, including total assets, net profit, earnings per share, quarterly financial data, shareholder information, and notes on audit opinions. The document also references the full annual report and audit opinions by the accounting firm. The length of the document (12,482 characters) and the presence of substantive financial data and analysis confirm it is a financial report, not just an announcement. Therefore, this document is the Annual Report (10-K equivalent) or its summary. Given the detailed financial data and the nature of the document, the best classification is Annual Report (10-K).
2023-04-17 Chinese
2022年度独立董事述职报告（程鑫先生）
Board/Management Information Classification · 95% confidence The document is a detailed report by an independent director of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. for the year 2022. It includes descriptions of board meeting attendance, independent opinions on various board resolutions, onsite inspections, committee work, protection of minority shareholders, training, and other duties performed during the year. The content focuses on the independent director's duties and oversight rather than financial results or audit opinions. It is a formal report on the independent director's activities and opinions for the year, which aligns with the nature of a Board/Management Information filing rather than an Annual Report, Audit Report, or other categories. The document length is 2646 characters, which is relatively short but contains substantive content about board and management activities. Therefore, the best classification is Board/Management Information (MANG).
2023-04-17 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.